Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

• Vatier C, Gautier JF and Vigouroux C, 2012. Therapeutic use of recombinant methionyl human leptin. Biochimie, 94(10), pp.2116-2125. View at Publisher | View at Google Scholar | View at Indexing

• Hegde S, Schmidt M (2007) To market, to market–2006. Annual reports in medicinal chemistry 42:505-554.

  View at Publisher | View at Google Scholar

• Batarseh KI (2009) Antimicrobial, In Vitro and In Vivo Antineoplastic Activities, Mechanism of Action, Structural and Thermal Properties of a Small-Novel Pharmaceutical Organometallic Chelate. Mini reviews in medicinal chemistry 9: 293-299.

  View at Publisher | View at Google Scholar
• Oddi S, Fezza F, Catanzaro G, De Simone C, Pucci M, et al. (2010) Pitfalls and solutions in assaying anandamide transport in cells. Journal of lipid research. 51:2435-2444.
  View at Publisher | View at Google Scholar

• Smith KM. Investigation of Natural Product Scaffolds for the Development of Opioid Receptor Ligands (Doctoral dissertation, University of Kansas).

  View at Publisher | View at Google Scholar

• Clinical value of total colorectal resection of ileal pouch anorectal anastomosis in the treatment of ulcerative colitis (2014) Chinese Journal of Digestive Surgery 13: 612-616.

  View at Publisher | View at Google Scholar

• Di Blasio AM, Vignali M, Gentilini D (2013) The endocannabinoid pathway and the female reproductive organs. Journal of molecular endocrinology. 50: R1-9.

  View at Publisher | View at Google Scholar

• Dhal PK, Huval CC, Holmes-Farley SR (2007) Biologically active polymeric sequestrants: Design, synthesis, and therapeutic applications. Pure and Applied Chemistry 79: 1521-1530.

  View at Publisher | View at Google Scholar
• Davis C, Mudd J and Hawkins M, 2014. Neuroprotective effects of leptin in the context of obesity and metabolic disorders. Neurobiology of disease, 72, pp.61-71. View at Publisher | View at Google Scholar | View at Indexing
• Oddi S, Spagnuolo P, Bari M, D'Agostino A, Maccarrone M (2007) Differential modulation of type 1 and type 2 cannabinoid receptors along the neuroimmune axis. International review of neurobiology. 82:327-337.
  View at Publisher | View at Google Scholar

• Nalamachu SR, Pergolizzi J, Taylor R, Slatkin NE, Barrett AC,et al. (2015) Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid‐Induced Constipation: A Responder Analysis of 2 Randomized, Placebo‐Controlled Trials. Pain Practice15: 564-71.

  View at Publisher | View at Google Scholar

• Polomoscanik SC, Holmes-Farley SR, Petersen JS, Sacchiero RJ, Dhal PK (2012) Hydrophobically Modified Poly (Allylamine) Hydrogels Containing Internal Quaternary Ammonium Groups as Cholesterol Lowering Agents: Synthesis, Characterization, and Biological Studies. Journal of Macromolecular Science, Part A 49: 1011-1021.

  View at Publisher | View at Google Scholar
• Farr OM, Gavrieli A and Mantzoros CS, 2015. Leptin applications in 2015: what have we learned about leptin and obesity?. Current opinion in endocrinology, diabetes, and obesity, 22(5), p.353. View at Publisher | View at Google Scholar | View at Indexing

• Hanuschak T. Coronary Angiography and Neurologically Intact Survival in Out-of-Hospital Cardiac Arrest Patients with Return of Spontaneous Circulation.

  View at Publisher | View at Google Scholar
• Dainese E, Gasperi V, Maccarrone M (2005) Partial QSAR analysis of some selected natural inhibitors of FAAH suggests a working hypothesis for the development of endocannabinoid-based drugs. Current Drug Targets-CNS & Neurological Disorders. 4: 709-714.
  View at Publisher | View at Google Scholar

• Kang JH, Oh SY, Song SY, Lee HY, Kim JH, et al. (2015) The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe pain. The Korean journal of internal medicine 30: 88.

  View at Publisher | View at Google Scholar

• Booker KJ, Andrews LK (2016) Vital measurements and shock syndromes in critically ill adults. Critical Care Nursing: Monitoring and Treatment for Advanced Nursing Practice 19: 13-34.

  View at Publisher | View at Google Scholar
• Folch J, Patraca I, Martínez N, Pedrós I, Petrov D, et al. 2015. The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin. Life sciences, 140, pp.19-28. View at Publisher | View at Google Scholar | View at Indexing
• Anderson G and Maes M, 2013. Metabolic syndrome, alzheimer disease, schizophrenia, and depression: Role for leptin, melatonin, kynurenine pathways, and neuropeptides. Metabolic syndrome and neurological disorders, pp.235-248. View at Publisher | View at Google Scholar | View at Indexing

• Woerlee GM (2011) Could Pam Reynolds hear? A new investigation into the possibility of hearing during this famous near-death experience. Journal of Near-Death Studies 30: 3-25.

  View at Publisher | View at Google Scholar
• Maccarrone M (2010) The endocannabinoid system and its manifold central actions. Handbook of Neurochemistry and Molecular Neurobiology: Neural Lipids. 385-405.
  View at Publisher | View at Google Scholar

• Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H (2007) Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. The Lancet 369: 482-490.

  View at Publisher | View at Google Scholar

• Sullivan JM, O’neil BJ (2011)Into the age of reanimation: promise and challenge in cardiac arrest care. Therapy 8: 673-675.

  View at Publisher | View at Google Scholar

• Sharma M and Hölscher C, 2014. The neurophysiological and neuroprotective effects of leptin. JSM Alzheimer’s Dis Related Dementia, 1, p.1009pp.

  View at Publisher | View at Google Scholar
• Maccarrone M, Oddi S, Fezza F, Agro AF, inventors; Universita Degli Studi Di Roma “Tor Vergata”, Universita Degli Studi Di Teramo, assignee (2011) Design and synthesis of biotinylated probes for N-acyl-ethanolamines. United States patent US 7,955,816. .
  View at Publisher | View at Google Scholar
• Li XM, Yan HJ, Guo YS and Wang D, 2016. The role of leptin in central nervous system diseases. Neuroreport, 27(5), p.350. View at Publisher | View at Google Scholar | View at Indexing

• Gao D, Li N, Li Q, Li J, Han Z, et al. Study of the extraction, purification and antidiabetic potential of ursolic acid from Cornus officinalis Sieb. et Zucc.

  View at Publisher | View at Google Scholar

• Smith HS (2009) Opioids: maximizing efficacy, minimizing adverse effects. Therapy 6: 629-31.

  View at Publisher | View at Google Scholar
• Araújo V, William-Amarelle C, Sanchez-Iglesias S, Castro A and Casanueva FF, 2014. Therapeutic use of recombinant human leptin Therapeutic use of recombinant leptin. Pediatr Endocrinol Rev Esp, 5 (1), pp.27-42. View at Publisher | View at Google Scholar | View at Indexing

• Dong W, Zhen Y (2014) Nephro-Protective Effect of Cortex Lycii Radicis Extracts in Streptozotocin-Induced Diabetic Rats. Current Signal Transduction Therapy 9: 106-111.

  View at Publisher | View at Google Scholar
• Nagaoka U, Shimizu T and Uchihara T, 2015. Leptin upregulation in advanced multiple system atrophy with hypocholesterolemia and unexpected fat accumulation. Neurological Sciences, 36(8), pp.1471-1477. View at Publisher | View at Google Scholar | View at Indexing
• Salameh TS, Rhea EM, Banks WA and Hanson AJ, 2016. Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease. Experimental Biology and Medicine, 241(15), pp.1676-1683. View at Publisher | View at Google Scholar | View at Indexing

• Smith HS (2009) Opioids: maximizing efficacy, minimizing adverse effects. Therapy 6: 629-31.

  View at Publisher | View at Google Scholar

• Berghaus LJ, Giguère S, Guldbech K (2013) Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi. Veterinary microbiology 166: 670-675.

  View at Publisher | View at Google Scholar

• Vidal K, Blum-Sperisen S, Philippe D, Ballevre O, Bucheli P, et al. (2015) Wolfberries and skin inflammation. United States patent US 9,072,769.

  View at Publisher | View at Google Scholar
• Sánchez JC, Ospina JP and González MI, 2013. Association between leptin and delirium in elderly inpatients. Neuropsychiatric disease and treatment, 9, p.659. View at Publisher | View at Google Scholar | View at Indexing

• ZHANG ZF, LI YY, BAIBADO JT, CHEUNG HY (2012) Bioactive Substances and Medicinal Effects of Lycii Cortex. EDITIORIAL COMMITTEE 118.

  View at Publisher | View at Google Scholar
• Rapkin AJ, Berman SM and London ED, 2014. The cerebellum and premenstrual dysphoric disorder. AIMS Neurosci, 1, pp.120-41. View at Publisher | View at Google Scholar | View at Indexing

• Metzler K, Drlica K, Blondeau JM (2013) Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 68: 631-635.

  View at Publisher | View at Google Scholar

• LiújÄ«nlíng, Zhuāng Y, Yáng L, Zhāng Y, Qiáo W (2013) Preliminary study on the effect of peanut tetraenethanolamine on platelet preservation in vitro. International Journal of Blood Transfusion and Hematology. 36 : 389-394.

  View at Publisher | View at Google Scholar
• Mukaetova-Ladinska EB and Boksha IS, 2015. Is blood leptin a biomarker for dementia development?. View at Publisher | View at Google Scholar | View at Indexing
• Curcio L (2012) Effetti dell'iperinsulinemia acuta sul sistema endocannabinoide del tessuto adiposo. Ludovica Curcio.
  View at Publisher | View at Google Scholar

• Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A (2012) Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F. Oseltamivir–zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A (H1N1) virus infections. Antiviral research. 296: 130-137.

  View at Publisher | View at Google Scholar

• Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A (2012) Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F. Oseltamivir–zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A (H1N1) virus infections. Antiviral research. 296: 130-137.

  View at Publisher | View at Google Scholar

• Smith HS (2009) Opioids: maximizing efficacy, minimizing adverse effects. Therapy 6: 629-31.

  View at Publisher | View at Google Scholar
• Johnston JM, Perry G, Ashford JW and Tezapsidis N, LEPTIN IN ALZHEIMER’S DISEASE AND OTHER COGNITIVE DISORDERS AND ASSOCIATION WITH UNDERLYING LIPID ABNORMALITIES. BIOSYNTHESIS, FUNCTIONS AND CLINICAL SIGNIFICANCE, p.1. View at Publisher | View at Google Scholar | View at Indexing

• Tillotson GS, Doern GV, Blondeau JM (2006) Optimal antimicrobial therapy: the balance of potency and exposure. Expert opinion on investigational drugs 15: 335-337.

  View at Publisher | View at Google Scholar

• Gaymard A, Le Briand N, Frobert E, Lina B, Escuret V (2016) Functional balance between neuraminidase and haemagglutinin in influenza viruses. Clinical Microbiology and Infection 22: 975-983.

  View at Publisher | View at Google Scholar

• Blondeau JM (2006) Update on the use of the macrolides for community-acquired respiratory tract infections.

  View at Publisher | View at Google Scholar

• Manchikanti L, Benyamin R, Datta S, Vallejo R, Smith H (2010) Opioids in chronic noncancer pain. Expert review of neurotherapeutics 10: 775-89.

  View at Publisher | View at Google Scholar